Table 1.
Use |
Frequency |
|||
---|---|---|---|---|
Marijuana (n = 458; nobs = 1356) |
Other Drugs (n = 458; nobs = 1356) |
Marijuana (n = 363; nobs = 871) |
Other Drugs (n = 141; nobs = 250) |
|
OR [95 % CrI] | OR [95 % CrI] | OR [95 % CrI] | OR [95 % CrI] | |
During Pandemic | 0.84 [0.60, 1.19] | 0.61 [0.37, 0.96] | 1.21 [0.94, 1.55] | 1.75 [1.01, 3.05] |
With Covariates | ||||
During Pandemic | 0.83 [0.58, 1.20] | 0.60 [0.37, 0.94] | 1.22 [0.94, 1.57] | 1.79 [1.02, 3.21] |
Age | 0.86 [0.75, 0.98] | 0.98 [0.85, 1.14] | 0.99 [0.89, 1.12] | 1.17 [0.97, 1.41] |
HIV Positive | 5.26 [1.8, 15.62] | 0.94 [0.29, 3.26] | 8.46 [3.53, 20.67] | 0.23 [0.03, 1.36] |
Gender Identity | ||||
Male (Reference) | – | – | – | – |
Transgender Female | 0.38 [0.05, 3.00] | 4.62 [0.46, 48.96] | 1.69 [0.24, 12.22] | 2.38 [0.21, 31.32] |
Other | 1.32 [0.17, 10.99] | 3.43 [0.34, 29.56] | 4.58 [0.79, 29.10] | 3.51 [0.30, 46.90] |
Note. All models include a random intercept to account for multiple observations of participants. Model intercepts are not shown. nobs indicates the number of observations provided by participants for each analysis.